Pharmaceutical formulations and methods of use which combine non-steroidal anti-inflammatory compounds with anti-hypertensive compounds

作者: Peter C. Hoyle , Paul Waymack

DOI:

关键词:

摘要: An oral dosage form of a non-steroidal anti-inflammatory drug (NSAID) is rendered safer for extended or chronic use anti-inflammatory, analgesic antipyretic therapy by combining it with an antihypertensive drug. The acts prophylactically to inhibit reduce NSAID-induced hypertension and so doing the adverse cardiovascular side effects NSAIDs, such as high blood pressure, heart attack, stroke, opththamologic complications, death, when NSAIDs are used repetitively over period time reducing inflammation in pain management.

参考文章(8)
Newell Bascomb, Frederic S. Young, John Maki, Compositions and methods for ameliorating cachexia ,(2006)
Consuelo Huerta, Jordi Castellsague, Cristina Varas-Lorenzo, Luis Alberto García Rodríguez, Nonsteroidal anti-inflammatory drugs and risk of ARF in the general population. American Journal of Kidney Diseases. ,vol. 45, pp. 531- 539 ,(2005) , 10.1053/J.AJKD.2004.12.005
Garret A. FitzGerald, Coxibs and Cardiovascular Disease The New England Journal of Medicine. ,vol. 351, pp. 1709- 1711 ,(2004) , 10.1056/NEJMP048288
Mark C. Houston, Nonsteroidal anti-inflammatory drugs and antihypertensives The American Journal of Medicine. ,vol. 90, ,(1991) , 10.1016/0002-9343(91)90485-G
Félix M. Arellano, Marianne Ulcickas Yood, Charles E Wentworth, Susan A Oliveria, Elena Rivero, Anila Verma, Kenneth J Rothman, Use of cyclo‐oxygenase 2 inhibitors (COX‐2) and prescription non‐steroidal anti‐inflammatory drugs (NSAIDS) in UK and USA populations. Implications for COX‐2 cardiovascular profile Pharmacoepidemiology and Drug Safety. ,vol. 15, pp. 861- 872 ,(2006) , 10.1002/PDS.1343
Wim Vandenhouweele, Jeffrey Dayno, Combination therapy for the treatment or prevention of migraine ,(2004)
Jeffrey D. Lazar, Joseph F. Souhrada, Svetislav K. Vanov, Method for treating congestive heart failure ,(1991)